ColorectalArchives
Analysis of the effect of fecal SDC2, ADHFE1 and PPP2R5C gene methylation test for screening colorectal cancer in the Otog Front Banner
Colorectal 5 min.
Colorectal cancer (CRC) is the third most prevalent cancer worldwide and the second leading cause of death due to cancer [1]. Most CRCs follow an"adenoma-carcinoma"progression, evolving from precancerous lesions to cancer [2, 3]. It is estimated that it takes 5 to 10 years for CRC to develop from precancerous...
Suppressor protein plasma levels and inflammatory indices in colorectal cancer patients
Colorectal 4 min.
Currently, colorectal cancer is the third most common oncological disease. According to Globocan (https://gco.iarc.fr/en), approximately 1,900,000 new cases of colorectal cancer (CRC) are detected annually worldwide, and deaths have exceeded 930,000. Notably, the mortality rate is the highest in Eastern...
Dietary intake and tissue biomarkers of omega-6 fatty acids and risk of colorectal cancer in adults: a systematic review and dose-response meta-analysis of prospective cohort studies
Colorectal 7 min.
Colorectal cancer (CRC) is a prevalent gastrointestinal cancer worldwide [1], with its incidence increasing at an alarming rate and predicted to reach 2.5 million new cases by 2035. CRC is the fourth leading cause of cancer-related deaths worldwide, accounting for more than 900,000 deaths annually [1,...
The impact of KRAS mutations on risk of venous thromboembolism recurrence in patients with metastatic colorectal cancer
Colorectal 5 min.
Multiple studies have explored the association between different cancer types and the risk of venous thromboembolism (VTE) [1, 2–3]. Generally, aggressive cancers, marked by short survival times and early metastatic spread, are linked to a higher incidence of venous thrombosis [4]. Although colorectal...
